72
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Etizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo

, &
Pages 215-223 | Received 04 Jun 1990, Published online: 12 Aug 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Caroline Hunt & Michelle Singh. (1991) Generalized anxiety disorder. International Review of Psychiatry 3:2, pages 215-229.
Read now

Articles from other publishers (24)

Abdul Aziz Al Bahri & Hilary J Hamnett. (2023) Etizolam and Its Major Metabolites: A Short Review. Journal of Analytical Toxicology 47:3, pages 216-226.
Crossref
Christena Watts & Teri L Martin. (2022) Etizolam Blood Concentrations in 191 Forensic Cases in Ontario, Canada (2019–2020). Journal of Analytical Toxicology 46:7, pages 719-725.
Crossref
Ben C Smith, Thomas Grant & Bradley Allen. (2022) Excipient lung disease in a patient taking the benzodiazepine derivative etizolam: A case report. Radiology Case Reports 17:4, pages 1037-1040.
Crossref
Peter Zwanzger. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 9 .
Peter Zwanzger. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 2161 2169 .
Jirair Gevorkyan, Juliet Kinyua, Sue Pearring & Luke N Rodda. (2021) A Case Series of Etizolam in Opioid-Related Deaths. Journal of Analytical Toxicology 45:7, pages e4-e17.
Crossref
V. Kolbe, D. Rentsch, D. Boy, B. Schmidt, R. Kegler & A. Büttner. (2020) The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine. International Journal of Legal Medicine 134:5, pages 1727-1731.
Crossref
Suzanne Nielsen & Andrew McAuley. (2020) Etizolam: A rapid review on pharmacology, non‐medical use and harms. Drug and Alcohol Review 39:4, pages 330-336.
Crossref
Francesco Paolo Busardò, Annagiulia Di Trana, Eva Montanari, Simona Mauloni, Adriano Tagliabracci & Raffaele Giorgetti. (2019) Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance. Forensic Science International 301, pages 137-141.
Crossref
Elyse M. Cornett, Matthew B. Novitch, Andrew J. Brunk, Kelly S. Davidson, Bethany L. Menard, Richard D. Urman & Alan D. Kaye. (2018) New benzodiazepines for sedation. Best Practice & Research Clinical Anaesthesiology 32:2, pages 149-164.
Crossref
Kieran R. Manchester, Emma C. Lomas, Laura Waters, Fiona C. Dempsey & Peter D. Maskell. (2018) The emergence of new psychoactive substance (NPS) benzodiazepines: A review. Drug Testing and Analysis 10:1, pages 37-53.
Crossref
Mari Amino, Koichiro Yoshioka, Yuji Ikari & Sadaki Inokuchi. (2016) Long-term myocardial toxicity in a patient with tizanidine and etizolam overdose. Journal of Cardiology Cases 13:3, pages 78-81.
Crossref
Yushi Adachi, Hiromi Katoh, Taiga Itagaki, Katsumi Suzuki, Yukako Obata, Matsuyuki Doi & Shigehito Sato. (2010) . Nihon Shuchu Chiryo Igakukai zasshi 17:2, pages 219-220.
Crossref
Takuma Nakamae, Tatsuo Shinozuka, Chizuko Sasaki, Akira Ogamo, Chikako Murakami-Hashimoto, Wataru Irie, Masaru Terada, Shigeki Nakamura, Masataka Furukawa & Katsuyoshi Kurihara. (2008) Case report: Etizolam and its major metabolites in two unnatural death cases. Forensic Science International 182:1-3, pages e1-e6.
Crossref
T. Fukasawa, A. Suzuki & K. Otani. (2007) Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines. Journal of Clinical Pharmacy and Therapeutics 32:4, pages 333-341.
Crossref
T. Fukasawa, N. Yasui–Furukori, A. Suzuki, Y. Inoue, T. Tateishi & K. Otani. (2005) Pharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity. European Journal of Clinical Pharmacology 61:11, pages 791-795.
Crossref
Enrico Sanna, Fabio Busonero, Giuseppe Talani, Maria Cristina Mostallino, Maria Luisa Mura, Maria Giuseppina Pisu, Elisabetta Maciocco, Mariangela Serra & Giovanni Biggio. (2005) Low tolerance and dependence liabilities of etizolam: Molecular, functional, and pharmacological correlates. European Journal of Pharmacology 519:1-2, pages 31-42.
Crossref
S. Kondo, T. Fukasawa, N. Yasui-Furukori, T. Aoshima, A. Suzuki, Y. Inoue, T. Tateishi & K. Otani. (2005) Induction of the metabolism of etizolam by carbamazepine in humans. European Journal of Clinical Pharmacology 61:3, pages 185-188.
Crossref
Kristin Mitte, Peter Noack, Regina Steil & Martin Hautzinger. (2005) A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology 25:2, pages 141-150.
Crossref
Alastair J Flint. (2005) Generalised Anxiety Disorder in Elderly Patients. Drugs & Aging 22:2, pages 101-114.
Crossref
Paolo Meoni, David Hackett & Malcolm Lader. (2004) Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder. Depression and Anxiety 19:2, pages 127-132.
Crossref
C. Faravelli, S. Rosi & E. Truglia. 2002. Anxiety Disorders. Anxiety Disorders 313 338 .
W. L. Woolverton & M. A. Nader. (1995) Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline. Psychopharmacology 122:3, pages 230-236.
Crossref
Franco Benazzi, Marco Mazzoli & Emanuela Rossi. (2017) Auditory Hallucinations Suppressed by Etizolam in a Patient with Schizophrenia. The Canadian Journal of Psychiatry 38:8, pages 574-575.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.